- Future of Disruptive Tech
- Posts
- Your face reveals cancer outcomes while Wall Street embraces crypto revolution
Your face reveals cancer outcomes while Wall Street embraces crypto revolution
May 13th, 2025
If you know you need to learn how to use AI but you're not sure where to get started, then the team at Volaris has you covered. For just $27, you can get their step-by-step course for using AI to replace your day to day.
Read Time: 10 Minutes
Today’s Menu
AI turns facial features into powerful medical biomarkers
Markets surge as US-China trade tensions unexpectedly ease
Markets
Price | 1 Day Change |
---|
Bitcoin | $104,268 | 2.3% ⬆️ |
---|---|---|
Ethereum | $2,650 | 8.1% ⬆️ |
Solana | $178 | 4.7% ⬆️ |
TODAY IN AI
AI turns facial features into powerful medical biomarkers
In a breakthrough that challenges conventional medical assessment, researchers at Mass General Brigham have unveiled FaceAge—an AI system that analyzes facial photographs to estimate biological age and predict cancer survival outcomes with remarkable accuracy.
The technology, trained on tens of thousands of facial images, translates subtle features into biological age estimates that provide meaningful health insights. Cancer patients in the study appeared approximately five years older than their chronological age, with those looking oldest showing significantly worse survival rates.
When physicians incorporated FaceAge risk scores with traditional clinical data, their accuracy in predicting six-month survival improved dramatically. Even more compelling, the AI's predictions correlated with genes associated with cellular aging, suggesting FaceAge captures biological processes invisible to standard age measurements.
This represents a quantification of what skilled physicians have intuitively observed for decades—that a patient's appearance often contains valuable diagnostic information. By transforming these observations into measurable biomarkers, FaceAge creates a non-invasive window into physiological aging processes that could revolutionize treatment personalization.
The implications extend beyond cancer care. This technology could eventually screen populations for early disease detection, assess biological responses to treatments, or monitor aging processes in ways current methods cannot. For patients, this could mean earlier interventions and more precisely tailored treatment plans based on their individual biological aging profile rather than generic protocols.
Today In Crypto
Coinbase joining S&P 500 marks crypto's mainstream takeover
Coinbase's imminent addition to the S&P 500 represents more than just corporate recognition—it's the moment cryptocurrency officially infiltrates the financial establishment. The inclusion will force approximately $15 billion of institutional capital into COIN stock, according to Bitwise estimates.
This isn't just another company joining an index. It's the symbolic replacement of traditional finance with digital assets, as Coinbase quite literally takes Discover's spot—pushing a conventional payments company out of the index. The market has already responded enthusiastically, with COIN stock surging over 21% since the announcement, far exceeding the typical 3-8% bump most companies experience after S&P inclusion.
The mandatory allocation mechanics mean that virtually every pension fund, 401(k), and retirement account in America will soon own a piece of Coinbase, whether they embrace crypto or not. This creates the delicious irony that millions of crypto skeptics will become indirect Coinbase investors through their index-tracking retirement accounts.
The $15 billion influx represents about 30% of Coinbase's pre-announcement market cap, potentially creating significant sustained demand for the stock. This capital injection isn't speculative money—it's structural, long-term investment from the most conservative corners of finance.
The strategic significance cannot be overstated. Crypto has completed its journey from fringe technology to component of America's financial backbone. For industry participants, this milestone validates years of persistence through skepticism and regulatory uncertainty. For investors, it signals that digital asset exposure is transitioning from optional to essential in a balanced portfolio.
What I’m Reading - 1 Click Signup:
The Neuron - Daily AI Trends and Tools
Strategy Breakdowns - Business Growth Hacks and Tactics
What Did You Think of Today's Email? |
Want to share The Future of Disruptive Tech with a friend, family member, or coworker? Pass this link along to them.
Thanks for reading!
Until next time,
P.S. Want To Subscribe To My Personal Newsletter?
If you’re interested in learning more about disruptive tech, marketing, and everything else I’m exploring from day to day, then click here to subscribe to my personal list now.
Reply